Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 151 AL 165

Dietary Interventions to Prevent or Delay Alzheimer's Disease: What the Evidence Shows

Bartochowski Z, Conway J, Wallach Y, Chakkamparambil B, Alakkassery S, Grossberg GT.

Curr Nutr Rep. 2020 Sep;9(3):210-225. doi: 10.1007/s13668-020-00333-1.

Pathogenesis and promising therapeutics of Alzheimer disease through eIF2α pathway and correspondent kinases

Moradi Majd R, Mayeli M, Rahmani F.

Metab Brain Dis. 2020 Dec;35(8):1241-1250. doi: 10.1007/s11011-020-00600-8. Epub 2020 Jul 17.

Passive immunotherapies targeting Aβ and tau in Alzheimer's disease

Plotkin SS, Cashman NR.

Neurobiol Dis. 2020 Oct;144:105010. doi: 10.1016/j.nbd.2020.105010. Epub 2020 Jul 16.

Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer's disease or should they be looking elsewhere?

Imbimbo BP, Ippati S, Watling M.

Expert Opin Drug Discov. 2020 Nov;15(11):1241-1251. doi: 10.1080/17460441.2020.1793755. Epub 2020 Jul 20.

Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets

Royea J, Hamel E.

Geroscience. 2020 Oct;42(5):1237-1256. doi: 10.1007/s11357-020-00231-y. Epub 2020 Jul 22.

An evaluation on potential anti-inflammatory effects of β-lapachone

Mokarizadeh N, Karimi P, Kazemzadeh H, Fathi Maroufi N, Sadigh-Eteghad S, Nikanfar S, Rashtchizadeh N.

Int Immunopharmacol. 2020 Oct;87:106810. doi: 10.1016/j.intimp.2020.106810. Epub 2020 Jul 21.

Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations

Maramai S, Benchekroun M, Gabr MT, Yahiaoui S.

Biomed Res Int. 2020 Jun 30;2020:5120230. doi: 10.1155/2020/5120230. eCollection 2020.

Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer's Disease Therapy

Zagórska A, Jaromin A.

Molecules. 2020 Jul 23;25(15):3337. doi: 10.3390/molecules25153337.

Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer's Disease

Sharma VK, Singh TG, Singh S.

Curr Drug Targets. 2020;21(13):1371-1384. doi: 10.2174/1389450121666200727104728.

Psychometric characteristics of the Iranian Caregiver Burden Inventory (CBI) in caregivers of elderly patients with Alzheimer

Shafiezadeh A, Heravi-Karimooi M, Mirzaee A, Rejeh N, Sharif Nia H, Montazeri A.

Health Qual Life Outcomes. 2020 Jul 29;18(1):255. doi: 10.1186/s12955-020-01509-7.

Exercise training improves vascular function in patients with Alzheimer's disease

Pedrinolla A, Venturelli M, Fonte C, Tamburin S, Di Baldassarre A, Naro F, Varalta V, Giuriato G, Ghinassi B, Muti E, Smania N, Schena F.

Eur J Appl Physiol. 2020 Oct;120(10):2233-2245. doi: 10.1007/s00421-020-04447-w. Epub 2020 Jul 30.

Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches

Kellar D, Craft S.

Lancet Neurol. 2020 Sep;19(9):758-766. doi: 10.1016/S1474-4422(20)30231-3. Epub 2020 Jul 27.

Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease

Qu Z, Sun J, Zhang W, Yu J, Zhuang C.

Free Radic Biol Med. 2020 Nov 1;159:87-102. doi: 10.1016/j.freeradbiomed.2020.06.028. Epub 2020 Jul 28.

Involvement of GABAergic interneuron dysfunction and neuronal network hyperexcitability in Alzheimer's disease: Amelioration by metabolic switching

Mattson MP.

Int Rev Neurobiol. 2020;154:191-205. doi: 10.1016/bs.irn.2020.01.006. Epub 2020 Jul 10.

Status and future directions of clinical trials in Alzheimer's disease

Plascencia-Villa G, Perry G.

Int Rev Neurobiol. 2020;154:3-50. doi: 10.1016/bs.irn.2020.03.022. Epub 2020 Jul 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias